NEWT同业对比
NEWT 与SIC 6021 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NEWT本股 | $350M#6 | 5.5x#2 | 0.8x#1 | — | — | 19.0%#12 | — | 14.6%#1 | 11.6%#8 | — | — | 8.0%#1 |
| AROW | $719M#1 | 12.5x#8 | 1.6x#10 | — | — | 48.0%#7 | — | 9.8%#7 | 15.5%#6 | — | 36.6%#2 | 2.6%#6 |
| BCAL | $710M#2 | 12.0x#7 | 1.2x#3 | — | — | 1060.6%#1 | — | 10.7%#6 | 23.6%#3 | — | 29.0%#4 | 0.5%#9 |
| CARE | $691M#3 | 5.4x#1 | 1.3x#4 | 34.0x#3 | 4.6%#3 | 27.9%#9 | 561.7%#3 | 5.8%#12 | — | — | — | — |
| CBNK | — | — | — | — | — | 84.6%#5 | — | 13.5%#2 | — | — | — | — |
| SFST | — | — | — | — | 13.0%#1 | 95.5%#3 | 2221.4%#1 | 6.7%#11 | — | — | 39.4%#1 | — |
| PBAM | $511M#4 | — | 1.8x#11 | — | — | — | — | 0.0%#13 | — | — | — | — |
| FNLC | $399M#5 | 10.5x#3 | 1.4x#7 | — | — | 27.2%#10 | — | 11.7%#3 | 17.5%#5 | — | 36.2%#3 | 4.1%#3 |
| FDBC | $324M#7 | 10.6x#4 | 1.3x#5 | — | — | 35.6%#8 | — | 11.1%#5 | 33.5%#2 | — | 22.3%#6 | 2.9%#5 |
| FUNC | $289M#8 | 11.6x#6 | 1.4x#8 | 15.7x#1 | 4.0%#4 | 19.2%#11 | 308.4%#5 | 11.5%#4 | 18.8%#4 | — | — | 2.1%#8 |
| ATLO | $289M#9 | 21.9x#10 | 1.4x#6 | — | — | 86.2%#4 | — | 8.9%#8 | 34.4%#1 | — | — | 2.5%#7 |
| LCNB | $277M#10 | 11.2x#5 | 1.0x#2 | 42.9x#4 | — | 71.4%#6 | 797.5%#2 | 8.2%#9 | 11.7%#7 | — | 27.1%#5 | 4.5%#2 |
| NKSH | $275M#11 | 13.5x#9 | 1.4x#9 | 33.6x#2 | 9.8%#2 | 107.6%#2 | 498.0%#4 | 8.2%#10 | — | — | — | 3.5%#4 |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-16。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议